Dr. Torres completed his MD degree at Universidad del Valle (Cali, Colombia) in 2006. He then joined the International Center for Training and Medical Research (CIDEIM) in his home town, Cali, where he spent almost 3 years as a research assistant in the area of Gram negative Bacterial Resistance, where he published and presented his work in national and international journals and conferences.

After completing his Internal Medicine residency at Jacobi Medical Center in the Bronx, Dr. Torres completed his fellowship in Infectious Diseases at New York University (NYU). He then joined Englewood Hospital where he spent more than 2 years as an Infectious Disease consultant.

Dr. Torres joined Montefiore Medical Center/Albert Einstein College of Medicine in 2017 as an Assistant Professor. Since then, he has been providing PrEP, PEP, STI, HCV and HIV care to patients in the Bronx, as well as inpatient Infectious Disease consultation services at the hospital.  He has an interest to expand HIV prevention projects in Colombia and is working closely with Corporacion de Lucha contra el SIDA in Cali.

Dr. Torres has been a member of the Infectious Disease Society of America since 2012.

Selected Publications

·         Nori P, Szymczak W, Puius J, Sharma A, Cowman K, Fleischner Z, Bartash R, Chen V, Corpuz M, Gialanella P, Alpert P, Felsen U, Torres-Isasiga J, Guo Y. Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients.  Int J Antimicrob Agents. 56(6):106179. doi: 10.1016/j.ijantimicag.2020.106179. Epub 2020 Sep 25. (2020)

·         Mueses-Marín HF, Alvarado-Llano B, Torres-Isasiga J, Camargo-Plazas P, Bolívar-Rocha MC, Galindo-Orrego X, Martínez-Cajas JL. Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study. AIDS Research and Treatment, vol. 2021, Article ID 4789971, 11 pages (2021)

·         Falsey AR, et al., and the AstraZeneca AZD1222 Clinical Study Group (Julian A. Torres). Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med.  doi: 10.1056/NEJMoa21052902021. (2021).

·         Martínez-Cajas J, Alvarado-Llano B, Martínez-Buitrago E, Torres-Isasiga J, Arrivillaga M, Camargo P, Galindo-Orrego X, Mueses-Marín H. AC-2020-12-1420.R1 - HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study. AIDS Care. doi: 10.1080/09540121.2022.2029813 (2022)

·         Martínez-Cajas JL, Torres J, Mueses HF, Camargo Plazas P, Arrivillaga M, Gomez SA, Galindo X, Martínez Buitrago E, Alvarado-Llano BE. Applying Implementation Science Frameworks to Identify Factors that Influence the Intention of Healthcare Providers to Offer PrEP Care and Advocate for PrEP in HIV Clinics in Colombia: A Cross-Sectional Study. Implement Sci Commun. Mar 16; 3(1):31. doi.org/10.1186/s43058-022-00278-2 (2022)

·         Meyerowitz EA, Bernardo, RM, Collins-Ogle, MD, Mamber Czeresnia, J, Morales Matos, C, Mullis C, Root, H; Torres-Isasiga JA, Tsai, H; Zingman, B. Navigating HIV Screening Recommendations for People on PrEP and the Need to Update Testing Algorithms. Open Forum Infectious Diseases, ofac191. doi.org/10.1093/ofid/ofac191 (2022)

·         Arrivillaga M, Gómez SA, Mueses HF, Alvarado B, Martínez Buitrago E, Camargo-Plazas P, Hurtado LR, Bolívar MC, Galindo X, Torres J, Cajas-Martínez JL. Facilitadores y recomendaciones de proveedores de salud para la implementación de la Profilaxis Pre-Exposición en clínicas de VIH en Colombia. “Estudio PPrE-Colombia”. Rev Gerenc Polit Salud;21. https://doi.org/10.11144/Javeriana.rgps21.frps (2022)

·         Meyerowitz EA, Gendlina I, Desai VJ, Grossberg R, Nair SR, Pujar B, Riska PF, Root HB, Toro J, Torres JA, Pirofski LA, Zingman BS. Anorectal Testing for Monkeypox Virus Infection in Men who have Sex with Men with and without Proctitis. Clin Infect Dis. 2022 Oct 13:ciac825. doi: 10.1093/cid/ciac825. Epub ahead of print. PMID: 36227656 (2022)